These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3450719)

  • 21. A new model of ovarian carcinogenesis may influence early detection strategies.
    Burger RA
    Am J Obstet Gynecol; 2008 Apr; 198(4):349-50. PubMed ID: 18395029
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating tumour markers in ovarian tumours.
    von Schlippe M; Rustin GJ
    Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
    Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
    Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incidence of CA 125 antigen in the blood of women with ovarian carcinoma].
    Tosner J; Lacinová V; Louda B; Vanásek J
    Cesk Gynekol; 1987 Nov; 52(9):681-4. PubMed ID: 3482173
    [No Abstract]   [Full Text] [Related]  

  • 25. [CA-125 antigen].
    Zakrzewska I
    Postepy Hig Med Dosw; 2002; 56(1):29-38. PubMed ID: 11987487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of tumor marker CA 125 in the treatment of ovarian cancer].
    Porsbjerg CM; Sørensen JB; Lund BA
    Ugeskr Laeger; 1998 Feb; 160(7):995-1000. PubMed ID: 9477746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New advances in screening and treatment of ovarian cancer].
    Morice P; Pautier P; Bidart JM
    Bull Cancer; 2003 Jan; 90(1):53-60. PubMed ID: 12609805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor DNA as a prognostic factor.
    Rafii A; Querleu D
    Am J Obstet Gynecol; 2006 Jul; 195(1):335; author reply 336. PubMed ID: 16579938
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoimmune hemolytic anemia associated with ovarian cancer.
    Morris PG; Swords R; Sukor S; Fortune A; O'Donnell DM; Conneally E
    J Clin Oncol; 2008 Oct; 26(30):4993-5. PubMed ID: 18809611
    [No Abstract]   [Full Text] [Related]  

  • 30. The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.
    Andriole GL; Reding D; Hayes RB; Prorok PC; Gohagan JK;
    Urol Oncol; 2004; 22(4):358-61. PubMed ID: 15283897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ovarian carcinoma: certain characteristics of evolution, advancement and diagnosis].
    Prokopenko PG; Terent'ev AA
    Vopr Onkol; 2009; 55(2):143-50. PubMed ID: 19514366
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current situation and prospect of proteomics research in ovarian malignancies].
    Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):577-8. PubMed ID: 17181963
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tumor markers in epithelial ovarian cancer].
    Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G
    Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-scale proteomics analysis of human ovarian cancer for biomarkers.
    Bengtsson S; Krogh M; Szigyarto CA; Uhlen M; Schedvins K; Silfverswärd C; Linder S; Auer G; Alaiya A; James P
    J Proteome Res; 2007 Apr; 6(4):1440-50. PubMed ID: 17315909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of L1 in the progression of ovarian carcinomas.
    Altevogt P; Fogel M
    Zentralbl Gynakol; 2004 Oct; 126(5):323-5. PubMed ID: 15478051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer.
    Swisher EM; Wollan M; Mahtani SM; Willner JB; Garcia R; Goff BA; King MC
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):662-7. PubMed ID: 16150257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tumor marker in ovarian cancer].
    Komai K; Nishida T
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic markers for ovarian cancer screening: not ready for routine clinical use.
    Coates RJ; Kolor K; Stewart SL; Richardson LC
    Clin Cancer Res; 2008 Nov; 14(22):7575-6; author reply 7577-9. PubMed ID: 18948387
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer of the ovary.
    Kennedy I
    S Afr Med J; 1978 Apr; 53(14):524. PubMed ID: 675405
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tumor markers].
    el May M; Guermazi F; Kraiem A; M'Timet S
    Tunis Med; 1989 Jan; 67(1):3-9. PubMed ID: 2662542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.